EXCLUSIVE LICENSE AGREEMENT --------------------------- (SK#4771)Exclusive License Agreement • January 9th, 2006 • AngioGenex, Inc. • Communications services, nec • New York
Contract Type FiledJanuary 9th, 2006 Company Industry Jurisdiction
EXHIBIT 10.1 Confidential Treatment Requested. *** indicates material has been omitted pursuant to a Confidential Treatment Request filed with the Securities and Exchange Commission. A complete copy of this agreement has been filed separately with the...Exclusive License Agreement • November 15th, 2004 • Power 3 Medical Products Inc • Surgical & medical instruments & apparatus
Contract Type FiledNovember 15th, 2004 Company Industry
EXCLUSIVE LICENSE AGREEMENT for Sanguine Corporation Technologies PHER-02 Oxygen-Carrying Synthetic Substitute for Human Red Blood Cells U.S. Patent Pending, Assigned Serial Number 08/230,672 All Derivatives of PHER-02 TABLE OF CONTENTS RECITALS...Exclusive License Agreement • March 25th, 2002 • Sanguine Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledMarch 25th, 2002 Company Industry Jurisdiction